Il y a eu 46 transactions d'initiés récentes enregistrées pour Shuttle Pharmaceuticals Holdings, Inc. (SHPH), dont 8 achats et 26 ventes. Le total des achats d'initiés s'élève à $48K et le total des ventes d'initiés à $50.4K.
Les initiés notables ayant une activité récente comprennent Liang Yuying, Pathigoda Arachchige Sachin Eranga, Liriano Angel. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — SHPH
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-01-06 |
Liang Yuying |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-09-12 |
Pathigoda Arachchige Sachin Eranga |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-09-12 |
Liriano Angel |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-09-08 |
Chambers Adam V |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-08-08 |
Lorber Timothy J. |
Chief Financial Officer |
Attribution de RSU |
24,854 |
- |
- |
24,854 |
| 2025-08-08 |
Scorsis George |
Director |
Attribution de RSU |
29,240 |
- |
- |
29,240 |
| 2025-08-08 |
Nabyt Oleh |
Director |
Attribution de RSU |
29,240 |
- |
- |
29,240 |
| 2025-08-08 |
Tung Joseph |
Director |
Attribution de RSU |
29,240 |
- |
- |
29,240 |
| 2025-08-08 |
Richards Steven M |
Director |
Attribution de RSU |
29,240 |
- |
- |
29,240 |
| 2025-03-11 |
Cooper Chris |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-02-28 |
Scorsis George |
Director |
Inconnu |
- |
- |
- |
184,162 |
| 2025-02-28 |
Nabyt Oleh |
Director |
Inconnu |
- |
- |
- |
184,162 |
| 2025-02-28 |
Tung Joseph |
Director |
Inconnu |
- |
- |
- |
184,162 |
| 2024-12-31 |
Schafer Joshua |
Director |
Inconnu |
- |
- |
- |
- |
| 2024-12-31 |
Richards Steven M |
Director |
Inconnu |
- |
- |
- |
- |
| 2024-12-31 |
Brown Milton |
Director |
Inconnu |
- |
- |
- |
- |
| 2024-06-13 |
Lorber Timothy J. |
Chief Financial Officer |
Cession |
- |
- |
- |
227,635 |
| 2024-05-01 |
Jung Mira |
Chief Scientific Officer |
Retour de RSU |
598 |
$11.28 |
$6.75K |
135,715 |
| 2024-03-08 |
Vander Hoek Michael |
Chief Financial Officer |
Attribution de RSU |
100,000 |
- |
- |
103,852 |
| 2023-12-13 |
Brown Milton |
Director |
Vente Informative |
2,921 |
$0.46 |
$1.35K |
1,094,610 |
| 2023-12-13 |
Jacobs Bette |
Director |
Vente Informative |
4,157 |
$0.46 |
$1.93K |
27,064 |
| 2023-08-14 |
Dritschilo Anatoly |
10 Percent Owner, Officer: CEO and Chairman |
Don (Donné) |
2,100,000 |
- |
- |
1,104,407 |
| 2023-02-15 |
Brown Milton |
Director |
Attribution de RSU |
25,000 |
$1.92 |
$48K |
25,000 |
| 2022-12-29 |
Dritschilo Anatoly |
CEO and Chairman |
Vente Informative |
8,372 |
$1.61 |
$13.44K |
1,085,200 |
| 2022-12-29 |
Rich Tyvin |
Chief Medical Officer |
Vente Informative |
1,414 |
$1.61 |
$2.27K |
2,429 |
| 2022-12-29 |
Jung Mira |
Chief Scientific Officer |
Vente Informative |
328 |
$1.61 |
$526.44 |
1,071,388 |
| 2022-12-29 |
Jacobs Bette |
Director |
Vente Informative |
4,366 |
$1.61 |
$7.01K |
31,221 |
| 2022-12-29 |
Brown Milton |
Director |
Vente Informative |
995 |
$1.61 |
$1.6K |
1,072,531 |
| 2022-12-29 |
Adkins William |
Director |
Vente Informative |
995 |
$1.61 |
$1.6K |
184,071 |
| 2022-12-29 |
Richards Steven M |
Director |
Vente Informative |
995 |
$1.61 |
$1.6K |
1,707 |
| 2022-12-29 |
Senanayake Chris |
Director |
Vente Informative |
1,626 |
$1.61 |
$2.61K |
2,791 |
| 2022-12-29 |
Dritschilo Peter |
President and COO |
Vente Informative |
3,820 |
$1.61 |
$6.13K |
6,560 |
| 2022-12-29 |
Vander Hoek Michael |
Chief Financial Officer |
Vente Informative |
2,243 |
$1.61 |
$3.6K |
3,852 |
| 2022-10-28 |
Jacobs Bette |
Director |
Cession |
- |
- |
- |
35,587 |
| 2022-09-02 |
Adkins William |
Director |
Autre (Achat) |
138,889 |
- |
- |
138,889 |
| 2022-08-29 |
Dritschilo Peter |
President and COO |
Cession |
- |
- |
- |
10,380 |
| 2022-08-29 |
Dritschilo Anatoly |
10 Percent Owner, Officer: CEO and Chairman |
Cession |
- |
- |
- |
1,070,824 |
| 2022-08-29 |
Rich Tyvin |
Chief Medical Officer |
Cession |
- |
- |
- |
3,843 |
| 2022-08-29 |
Jung Mira |
Chief Scientific Officer |
Cession |
- |
- |
- |
1,071,716 |
| 2022-08-29 |
Vander Hoek Michael |
Chief Financial Officer |
Cession |
- |
- |
- |
6,095 |
| 2022-08-29 |
Adkins William |
Director |
Cession |
- |
- |
- |
280,480 |
| 2022-08-29 |
Schafer Joshua |
Director |
Cession |
- |
- |
- |
2,702 |
| 2022-08-29 |
Senanayake Chris |
Director |
Cession |
- |
- |
- |
3,843 |
| 2022-08-29 |
Richards Steven M |
Director |
Cession |
- |
- |
- |
2,702 |
| 2022-08-29 |
Dritschilo Anatoly |
10 Percent Owner, Officer: CEO and Chairman |
Cession |
- |
- |
- |
1,093,572 |
| 2022-08-29 |
Brown Milton |
Director |
Cession |
- |
- |
- |
1,073,526 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
